Skip to main content
Download PDF

Brainstem dysfunction in critically ill patients

Critical Care volume 24, Article number: 5 (2020) Cite this article

Abstract

The brainstem conveys sensory and motor inputs between the spinal cord and the brain, and contains nuclei of the cranial nerves. It controls the sleep-wake cycle and vital functions via the ascending reticular activating system and the autonomic nuclei, respectively. Brainstem dysfunction may lead to sensory and motor deficits, cranial nerve palsies, impairment of consciousness, dysautonomia, and respiratory failure. The brainstem is prone to various primary and secondary insults, resulting in acute or chronic dysfunction. Of particular importance for characterizing brainstem dysfunction and identifying the underlying etiology are a detailed clinical examination, MRI, neurophysiologic tests such as brainstem auditory evoked potentials, and an analysis of the cerebrospinal fluid. Detection of brainstem dysfunction is challenging but of utmost importance in comatose and deeply sedated patients both to guide therapy and to support outcome prediction. In the present review, we summarize the neuroanatomy, clinical syndromes, and diagnostic techniques of critical illness-associated brainstem dysfunction for the critical care setting.

Introduction: the concept of brainstem dysfunction

The brainstem is the caudal portion of the brain that connects the diencephalon to the spinal cord and the cerebellum [1]. The brainstem mediates sensory and motor pathways between the spinal cord and the brain and contains nuclei of the cranial nerves, the ascending reticular activating system (ARAS), and the autonomic nuclei. It controls the brainstem reflexes and the sleep-wake cycle and is responsible for the autonomic control of the cardiocirculatory, respiratory, digestive, and immune systems. Brainstem dysfunction may result from various acute or chronic insults, including stroke, infectious, tumors, inflammatory, and neurodegenerative diseases. In the context of critical illness, the brainstem can be susceptible to various insults that can be categorized as structural and non-structural origin. Brainstem dysfunction can then contribute to impairment of consciousness, cardiocirculatory and respiratory failure, and thus increased mortality [2,3,4,5].

In the present review, we describe brainstem functional neuroanatomy, clinical syndromes, and assessment methods before addressing the concept of critical illness-associated brainstem dysfunction.

Functional neuroanatomy of the brainstem

The brainstem can be categorized into three major parts: midbrain, pons, and medulla oblongata (Figs. 1 and 2). The brainstem contains both gray and white matter, with the basilar artery representing the vascular supply. The gray matter includes the nuclei of the cranial nerves (anterior part), the ARAS (posterior part), the extrapyramidal and the central autonomic nervous system (ANS). This gray matter controls brainstem reflexes, arousal, automatic movements, and homeostasis, respectively. The white matter is composed of ascending sensory pathways and descending pyramidal and extrapyramidal pathways (Table 1).

Fig. 1
figure 1

General anatomy of the brainstem and oculocephalic circuit. A Anatomical sagittal sections. B Representation of the sagittal section plans and of the oculocephalic circuit (ventral part)

Full size image
Fig. 2
figure 2

Anatomical axial sections of the brainstem. a Representation of the brainstem (dorsal part) and of the axial sections plans. b, c Midbrain axial sections. d Pons axial sections. e Medulla oblongata axial sections

Full size image
Table 1 Functional neuroanatomy for the intensivist
Full size table

Brainstem syndromes and assessment

Brainstem pathology should be considered in cases of (a) sensory or motor deficits combined with cranial nerve palsy, (b) impairment of consciousness, (c) dysautonomia, or (d) neurological respiratory failure.

Brainstem motor and sensory deficits and cranial nerve palsy

The pyramidal and extrapyramidal tracts connect the upper motor neurons and the extrapyramidal nuclei with the lower motor neurons located in either the brainstem or the spinal cord [6]. While the former controls voluntary movement, the latter is involved in reflexes, motion, complex movements, and postural control (Tables 1 and 2). Upper motor neuron damage can lead to symptoms, ranging from hemiparesis to the locked-in syndrome, which is typically characterized by intact awareness, quadriplegia, anarthria, and absence of eye movements except for preserved vertical gaze. It usually results from bilateral pontine white matter lesions [7]. Characteristic clinical features of brainstem lesions include ipsilateral cranial nerve palsies or cerebellar signs combined with contralateral motor deficits. Brainstem lesions may present with abnormal movements, such as hemichorea, hemiballism, dystonia, tremor, asterixis, pseudo-athetosis, and non-epileptic myoclonus [8] (Table 2). Bilateral motor corticobulbar tract lesion may present with swallowing impairment, dysphagia, dysphonia, velo-pharyngo-laryngeal impairments, uncontrollable crying/laughing episodes, and emotional lability (i.e., pseudobulbar affect; Table 2). A brainstem lesion of the posterior column-medial lemniscus pathway and the spinothalamic tract results in a contralateral proprioceptive/touch and temperature/pain deficit, respectively.

Table 2 Functional anatomy of the brainstem
Full size table

The testing of the cranial nerves and brainstem reflexes is described in Table 3. Abnormal spontaneous eye position and movements may be encountered in patients with brainstem lesions and can be seen in comatose patients. Assessment of pupillary size allows the diagnosis of third nerve lesion (i.e., mydriasis) or Horner’s syndrome (i.e., myosis, ptosis, enophtalmia, and anhidrosis). Pupillary light, corneal, oculocephalic, and gag reflexes are routinely assessed in the critical care setting. The oculovestibular responses and oculocardiac are less frequently tested, except to determine brain death. The absence of brainstem reflexes and spontaneous breathing is a prerequisite for the diagnosis of brain death [9]. Automated pupillometry could improve the assessment of the pupil light reflex and thereby its prognostic value [10]. Corneo-mandibular reflexes can be detected in acute brain injury, but its prognostic relevance remains controversial. Finally, assessments of primitive reflexes are less relevant in the ICU context but can be seen in patients with neurodegenerative disease (Table 3).

Table 3 Brainstem reflexes neuroanatomical and clinical description
Full size table

When suspecting brainstem lesions, MRI will have the highest yield to further localize and characterize brainstem lesions [6] (Table 4). Evoked potentials may be also useful for detecting a brainstem lesion. EEG [11] may be supportive in patients with abnormal movements and disorders of consciousness, and cerebrospinal fluid (CSF) analysis for those with suspected inflammatory or infectious diseases.

Table 4 Acute and chronic diseases involving the brainstem
Full size table

Impairment of consciousness

The ARAS controls the sleep-wake cycle and includes several nuclei mainly located in the pontine and midbrain tegmentum [12] (Table 2, Figs. 1 and 2): the rostral raphe complex, the parabrachial nucleus, the laterodorsal tegmental nucleus, the locus coeruleus (LC), the nucleus pontis oralis, the basal forebrain, and the thalamus. Monoaminergic neurons are directly linked to the cortex and are inhibited during deep sleep. Cholinergic pedunculopontine and laterodorsal tegmental nuclei are indirectly connected to the cortex via the thalamus and remain active during rapid eye movement sleep. These pathways are modulated by hypothalamic neurons [13].

Disorders of consciousness can be organized between acute and subacute or chronic [14]. Acute impairments of consciousness include coma which is defined as a “state of unresponsiveness in which the patient lies with eyes closed and cannot be aroused to respond appropriately to stimuli even with vigorous stimulation” [14]. The association of a prolonged non-responsive coma with a complete cessation of brainstem reflexes and functions suggests the diagnosis of brain death which is defined as an irreversible loss of all functions of the entire brain. Delirium is defined as an acute and fluctuating disturbance of consciousness, including attention and impairment of cognition, associated with motor hyperactivity or hypoactivity [15, 16]. Delirium has been associated with long-term cognitive impairment, functional disability in ICU survivors, and hospital mortality [15]. Brainstem dysfunction could account for some features of delirium, such as fluctuations in arousal and attentional impairment that could be related to ARAS and to ponto-mesencephalic tegmentum dysfunction, respectively. Other states of acute impairment of consciousness include clouding of consciousness and stupor, but they are less frequently used [14].

Subacute or chronic disorders of consciousness include the vegetative state (VS, also called Unresponsive Wakefulness Syndrome) defined as state of unresponsiveness in which the patient shows spontaneous eye opening without any behavioral evidence of self or environmental awareness [17]. The minimally conscious state (MCS) is defined as state of severely impaired consciousness with minimal behavioral evidence of self or environmental awareness, characterized by the presence of non-reflexive behavior (visual pursuit, appropriate motor response to painful stimulus) or even intermittent command following indicating a cortical integration [18, 19]. The VS and MCS are related to a preservation of brainstem arousal functions but with persistent impairment of supratentorial networks implicated in consciousness [20]. Stimulation of the ARAS may improve consciousness in vegetative or MCS patients [21]. In addition to deep brain stimulation, vagal nerve stimulation, which probably modulates the activity of the nucleus of the tractus solitarius and the dorsal raphe, has shown promising results [22].

In addition to these classical syndromes, other consciousness impairments have been described. Peduncular lesions can cause hallucinations [23] which may be encountered in ICU patients. More generally speaking, it is likely that brainstem dysfunctions account for a portion of the sleep-wake cycle impairments experienced by ICU patients. Brainstem lesions can induce cognitive deficits including impaired attention, naming ability, executive functioning, and memory impairment [24], ascribed to a disruption of interconnection between the frontal-subcortical system and the brainstem [1]. Finally, deep sedation is a pharmacologically induced coma, and its mechanisms of action involve the brainstem GABA and N-methyl-d-aspartate (NMDA) receptors [25].

Assessments of consciousness are based on neurological examination to confirm the diagnosis, determine the underlying cause, and evaluate the prognosis. In clinical practice, this assessment most commonly relies on the Glasgow Coma Scale (GCS) [20]. Focusing on the brainstem in particular, the FOUR (Full Outline of UnResponsiveness) score is to be preferred as it includes the corneal, pupil light, and cough reflexes and respiratory patterns [26]. In comatose patients, pupil sizes and reactivity can be suggestive of particular etiologies, such as drug overdose (myosis for opioids or mydriasis for tricyclic anti-depressants). In comatose brain-injured patients, brainstem reflex assessment is crucial to detect a uncal or downward cerebellar (tonsillar) herniation [10]. While the absence of corneal and pupillary light reflexes is strongly associated with poor outcome in post-anoxia, their prognostic value is less validated in other causes [27].

Patients with severe critical illness may be comatose due to sedation, which in clinical practice can be assessed using the RASS (Richmond Agitation Sedation Scale) [28]. In deeply sedated patients (i.e., RASS − 4 or − 5), the Brainstem Reflexes Assessment Sedation Scale (BRASS) might be useful to assess the effect of sedatives on the brainstem and potentially detect a brainstem dysfunction [29] (Table 5). The CAM-ICU and ICDSC are appropriate to monitor delirium [16, 30]. Finally, in VS and MCS patients, the Coma Recovery Scale-Revised has also been validated [20].

Table 5 Brainstem Reflexes Assessment Sedation Scale (BRASS)
Full size table

Coma due to structural brainstem lesions is predominantly related to pedunculo-pontine tegmental lesions, usually detected on MRI [12] (Table 4). Neurophysiological tests may be useful to assess the neurological prognosis in patients with impairment of consciousness. Somatosensory evoked potentials (SSEP) assess conduction from peripheral nerves (N9) to the somatosensory cortical (N20) regions passing through the brainstem (P14). Brainstem auditory evoked potentials (BAEP) are described in Table 6 [11]. Interestingly, sedation increases latencies and decreases amplitudes of evoked potentials in a dose-dependent manner but does probably not change the amplitudes with low to moderate doses used in ICU [31].

Table 6 BAEP waves and blink test
Full size table

The intracranial conduction time and intrapontine conduction time are assessed by measures of the P14–N20 inter-peak latency on SSEP and the III–V inter-peak latency on BAEP [11]. The prognostic value of BAEP has been explored in various causes of coma [32,33,34]. After cardiac arrest, the predictive value of BAEP for poor outcomes is limited [35]. However, in traumatic brain injury, preserved BAEP are associated with a good outcome [36]. Wave I can disappear if the auditory nerve is injured (traumatic or hypoxic injuries) [37].

Reactivity on EEG to auditory, visual, or nociceptive stimuli is important to assess after cardiac arrest because its absence is associated with poor outcome [38, 39]. Absent reactivity can result from a thalamus-brainstem loops and ARAS dysfunction [40,41,42,43]. The electrophysiological measurement of the blink reflex (Table 6) is a way to study the trigemino-facial loop [44], but its prognostic value in comatose patients remains insufficiently supported [45].

Autonomic nervous system impairment

The ANS plays a key role in homeostasis and allostasis by controlling vital functions and the immune system [46] and is composed of sympathetic (e.g., noradrenergic) and parasympathetic (e.g., cholinergic) systems. Sympathetic effects originate from the spinal cord (D1 to L3), while parasympathetic neuronal cell bodies are present in the nuclei of cranial nerves III (Edinger Westphal nuclei), VII, IX, and X and the sacral spinal cord (S2 to S4). Activation of the parasympathetic nervous system results in a decrease in heart rate (HR) and blood pressure (BP), and an increase in gastrointestinal tonus, vesical detrusor contraction, and myosis. Activation of the sympathetic system results in opposite effects. Cortical input can modulate responses in the ANS [46] as well as various receptors throughout the body, including the baroreceptors [47].

Brainstem injury may cause dysautonomic symptoms, which can be life-threatening [48] (Table 2). Cardiac arrhythmias frequently occur after brainstem stroke and are associated with increased mortality [48]. An intracranial hypertension-induced midbrain insult can impair parasympathetic control and thereby induce adrenergic storm. In brain death, there is a disappearance of the vasomotor tone and an impairment of myocardial contractility [49]. As exhaustive discussions of tests that allow testing of the ANS are beyond the scope of this review, we will focus on cardiovascular tests applicable to ICU patients. Standard monitoring allows for the detection of variations in HR and BP that can be suggestive of dysautonomia. However, the lack of apparent changes in cardiovascular signals does not rule out dysautonomia, which can be then assessed with the HR and BP spectral analysis. High frequency (HF) band (i.e., 0.15 to 0.4 Hz) variability of the HR is thought to predominantly reflect parasympathetic tone, while low frequency (LF) variability (i.e., 0.04 to 0.15 Hz) is primarily mediated by sympathetic activity. The LF/HF ratio reflects the sympathovagal balance. Therefore, spectral analysis allows studying the sympathetic, parasympathetic, and baroreflex activities both at rest and during stimulation [50]. If the Valsalva maneuver, the cold pressure test, and the pharmacological tests (with yohimbine or clonidine) allow testing the ANS, their use in ICU is very limited. Conversely, pupillometry is much more applicable for assessing dysautonomia in ICU. Thus, patients with dysautonomia present a pupil dilatation at resting state and a slow redilatation time [51].

Neurogenic respiratory failure

There are two types of muscles that play a major role in the respiratory system, dilatator muscles of the superior airway that are innervated by the brainstem via cranial nerves (motor neurons present in the V, VII, and XII nuclei) and contractor/pump muscles (diaphragm, intercostal, sternocleidomastoid, abdominal muscles) that are innervated by spinal motor neurons. They are controlled by bulbospinal (automatic command) and corticospinal (voluntary command) pathways. The respiratory drive originates from neurons of the latero-rostro-ventral medulla oblongata, which includes the pre-Botzinger complex and the parafacial respiratory group that control inspiration and expiration, respectively [52] (Table 2). This center receives various inputs to automatically adjust the respiratory drive to metabolic and mechanic changes [53]. Metabolic inputs are mediated by both peripheral (aortic and carotid) and central (medulla oblongata and LC) chemoreceptors [54]. The mechanical inputs are mediated by mechanoreceptors localized in the pulmonary parenchyma, bronchial wall, and muscle. At the level of the pons, the pedunculopontine tegmentum, the LC, the lateral parabrachial and Kölliker-Fuse nuclei are involved in the automatic respiratory control [55] (Table 2).

Automatic and voluntary control of respiratory motor neurons can be injured together or separately. For instance, automatic control is impaired in central congenital and acquired hypoventilation syndrome (i.e., Ondine syndrome), while voluntary control is preserved [56]. Acquired hypoventilation syndrome can result from brainstem tumoral, traumatic, ischemic, and inflammatory injuries [57], which implies the need for long-term mechanical ventilation.

Ventilator management may be significantly affected by brainstem lesions, and importantly, clinical features of neurological respiratory dysfunction are related to the localization of brainstem injury. The more caudal the lesion is, the more it is associated with an impairment of the respiratory drive. Midbrain injuries do not usually affect the respiratory rate (RR). Injuries to the upper pons increase the tidal volume and decrease the RR, while injuries of the lower pons are associated with respiratory asynchrony (e.g., ponto-peduncular injury). Ataxic breathing (irregular pauses and apnea periods) and central apnea are observed in rostro-ventral medulla oblongata injuries and associated with poor outcomes. Central neurogenic hyperventilation results from activation of the medullary respiratory center. Finally, yawning or refractory hiccups may be seen with lesions of the posterolateral medulla oblongata [58]. Swallowing impairment contributes also to the difficulty of weaning mechanical ventilation and can be an indication for a tracheostomy.

There are various structural and non-structural causes of neurological respiratory dysfunction, including infratentorial lesions, drug toxicity, heart failure, and sepsis [59,60,61]. Diagnosis relies on standard assessments of respiratory function (e.g., ventilator curves, tidal volumes (Vt), and RR in mechanically ventilated patients) but also on assessing the ventilatory response to hypercapnia (e.g., during a t-piece trial). An electromyogram of the respiratory muscles, notably the diaphragm, provides relevant information on the central drive. This technique may be helpful in patients that are impossible to wean from mechanical ventilation. As a caveat, it may be at times difficult to differentiate central respiratory dysfunction from critical illness neuropathy/myopathy. EMG and nerve conduction studies may help with the distinction, but limited assessments of every respiratory muscle group and available at highly specialized units limit this approach [62]. In mechanically ventilated patients, spirography can be performed (with the Vt/inspiration duration (Ti) ratio reflects the ventilatory command intensity) as well as the occlusion pressure measurement (i.e., P0.1). The latter reflects the “unconscious”/central respiratory command, but variability of its measurements limits routine application.

Brainstem dysfunction in critically ill patients

The leading causes of primary brainstem dysfunction are summarized in Table 4 and major differential diagnosis of brainstem dysfunction in Table 7. In the following section, we will discuss evidence for brainstem dysfunction encountered in critically ill patients beyond primary brainstem dysfunction.

Table 7 Differential diagnosis of brainstem dysfunction
Full size table

Clinical features

The “brainstem dysfunction” hypothesis originates from our study on usefulness of neurological examination in non-brain-injured critically ill patients who required deep sedation. These patients have usually a severe critical illness and therefore a higher risk to develop severe secondary brain insult [3, 29]. Furthermore, protracted deep sedation is still required in more than 30% of critically ill patients [63] and has been reported to be associated with increased mortality [63]. We found that assessment of brainstem reflexes was reproducible in this population [3, 29]. We also found that routinely used sedative and analgesic agents such as midazolam and fentanyl do not impair pupillary light, corneal, and cough reflexes in 90% of cases but depress oculocephalic response and grimacing to painful stimulation (absent in 50 and 70%, respectively) [3, 29, 63]. The cessation of brainstem reflexes results from the combining effects of critical illness (i.e., secondary brain insult), sedative, and analgesic agents. It is interesting to note that Guedel observed more than 70 years ago that sedative drugs abolish brainstem reflexes according to a sequential pattern (the loss of consciousness, followed by the cessation of brainstem reflexes in a rostro-caudal way until apnea) [64].

In deeply sedated non-brain-injured critically ill patients, the cessation of brainstem responses follows two distinct patterns. The first is characterized by a depression of whole brainstem responses (similar to Guedel’s description), and the second is characterized by a preferential impairment of the corneal reflex, the pupillary light reflex, and to a lesser extent the cough reflex, with paradoxical preservation of the oculocephalic response. The latter profile is associated with the severity of critical illness and the depth of sedation. Interestingly, this pattern cannot be ascribed to a unique focal brainstem lesion which most likely relies on a functional rather than a structural origin. This suggests that some neuroanatomical centers are more sensitive to deep sedation, critical illness, or both. Opioids might also contribute to brainstem dysfunction, as they depress the ARAS, respiratory centers, and brainstem reflexes (notably pupillary light and cough reflexes). However, morphine infusion rates did not differ in our study between the two cessation patterns of brainstem reflexes [29].

To assess brainstem reactivity in deeply sedated critically ill patients, we developed the BRASS [29] (Table 5). The principle of the BRASS development is not in agreement with the traditional paradigm of Jackson, which states that the brainstem reflexes are abolished in a rostro-caudal way. It thus differs from the FOUR score [65], which conditions the assessment of the cough reflex to the cessation of the pupillary light and corneal reflexes. Besides improving the prediction of mortality in deeply sedated patients, the assessment of brainstem reflexes, with help of either the BRASS or the FOUR score, might prompt the ICU physician to perform a brainstem imaging. It is however likely that the processes involved in critical illness-related brainstem dysfunction are radiologically assessable.

Electrophysiological, autonomic, and respiratory features of brainstem dysfunction

Neurophysiological tests provide further arguments for brainstem dysfunction in critically ill patients without primary brainstem injury. For instance, EEG is not reactive in 25% of patients with sepsis [42, 43], knowing that absence of reactivity can result from a dysfunction of the ARAS [40,41,42,43]. Middle latency BAEP responses and SSEP latencies were increased in 24% and 45% of deeply sedated non-brain-injured critically ill patients, respectively [34], indicating an impairment of the brainstem conduction. Interestingly, mean values of these latencies did not differ from those recorded in deeply sedated brain-injured patients.

Critical illness is also associated with decreased variability in HR and BP, with an impaired sympathetic tone and baroreflex [2, 50] and also with a reduced tidal volume variability [66] that can correlate with weaning failure. Since most of these findings concerned sedated patients, one may argue that sedative agents might be involved as a revealing or aggravating underlying insults. This hypothesis is further supported by the fact that increase in evoked potential latencies cannot be only ascribe to sedation since long-term swallowing disorders [67] and aspiration pneumonia are more frequent in sepsis survivors [68].

Thus, a multimodal assessment of brainstem dysfunction in critical illness is warranted. The undergoing multicenter PRORETRO study (ClinicalTrials.gov: NCT02395861) aims to evaluate a multimodal approach based on neurological examination and neurophysiological tests.

Mechanisms of brainstem dysfunction

Neuroimaging and neuropathological studies show that the brainstem is prone to vascular, inflammatory, and excitotoxic insults [5]. For instance, sepsis can be associated with impaired autoregulation of cerebral blood flow and microcirculatory dysfunction, which may compromise the brainstem perfusion. Second, a multifocal necrotizing leukoencephalopathy involving the brainstem can be secondary to an intense systemic inflammatory response [69]. Finally, the neuro-inflammatory process can culminate in neuronal apoptosis, which is evidenced in brainstem autonomic nuclei in patients who died from septic shock or in experimental sepsis [5]. Interestingly, it has been shown that apoptosis of autonomic nuclei can induce hypotension in septic rat [70].

Both humoral and neural pathways can induce a neuro-inflammatory process. The former involves the area postrema (Fig. 1), which allows the diffusion of circulating inflammatory mediators into the brainstem; the latter involves mainly the vagal nerve, which mediates the transmission of peripheral inflammatory signals to the brainstem [71, 72]. Autonomic brainstem nuclei are regulated by these two pathways, which then play a major role in the control of systemic inflammatory response.

Finally, metabolic processes can be involved. It is well known that electrolyte disturbances but also renal and liver failure impair brainstem responses, as illustrated by centro-pontine myelinolysis or by usefulness of FOUR score in hepatic encephalopathy [73].

Prognostic value of brainstem dysfunction and therapeutic perspective

The predictive value of the neurological examination findings and neurophysiological responses has been assessed in critically ill patients. There is a proportional relationship between the BRASS value and mortality. Interestingly, absence of a grimacing response associated with preserved oculocephalic responses is the most predictive of mortality [29], suggesting that prediction is better when first based on a combination of signs, and second, a decoupling process between the upper and lower part of the brainstem is involved [29]. The absence of EEG reactivity and of SSEP P14 response and increased P14–N20 SSEP latencies are associated with increased mortality [34, 42, 43]. Impaired HR variability and decreased sympathetic control are associated with mortality and organ failure [74].

There are arguments for a relationship between delirium and brainstem dysfunction. The drugs currently used for treating delirium are involving brainstem receptors. Thus, neuroleptics are antagonists of the dopamine D2 and serotoninergic 5HT2A receptors that are prevalent in the brainstem [75]. Dexmedetomidine is a selective agonist of alpha-2 receptor, notably at the level of the LC [76]. The role of the brainstem in patients with delirium is supported by these pharmacological data and further supported by neuropathological findings that demonstrate hypoxic and ischemic insults of the pons in delirious patients [77]. Absent oculocephalic responses and delayed middle-latency BAEP have been associated with delayed awakening or delirium after sedation discontinuation [34]. In neuroanatomical point of view, it is likely that cessation of the oculocephalic response reflects a dysfunction of the ARAS while cessation of the cough reflex reflects a dysfunction of the cardiovascular and respiratory autonomic nuclei. Finally, if conceivable, we do not know to what extent brainstem dysfunction contributes to long-term post-ICU mortality and functional disability.

Another contributing factor of the brainstem dysfunction in critical illness course might be the impaired sympatho-vagal control of the inflammatory response. The vagus nerve first senses and modulates peripheral inflammation, constituting the so-called cholinergic reflex [78]; second, it senses the microbiota metabolites, being a major component of the gut-brain axis [79] (Table 2). The adrenergic system controls the immune system, with alpha and beta-1 receptors being pro-inflammatory and beta-2 receptors anti-inflammatory [80]. It is therefore conceivable that a brainstem-related neuro-immune impairment can contribute to infection, organ failure, or death by facilitating a maladapted immune response. The modulation of the cholinergic reflex by α7nAChR agonists and by vagal nerve stimulation has been proposed in sepsis and critical illness to improve peripheral immune response and reduce organ dysfunction [81]. In addition to its peripheral immune effects, cholinergic modulation and vagal stimulation can promote anti-inflammatory microglial polarization [82]. However, we shall remind that rivastigmine, a cholinesterase inhibitor, is deleterious in critically ill patients. Vagal nerve stimulation is also proposed in refractory status epilepticus [83] and consciousness disorders [22], suggesting its potential but not yet demonstrated effect in critical illness-related encephalopathy. Beta-blockers reduce the mortality in cardiac diseases by attenuating the deleterious effects of sympathetic hyperactivation and increasing the vagal tone [84]. In sepsis, beta-blockers improve HR control, reduce systemic inflammation, and decrease mortality, acknowledging that their routine use is not yet warranted [85, 86].

Conclusion

Brainstem dysfunction can present with central sensory and motor deficits, cranial nerve palsies and abnormal brainstem reflexes, disorders of consciousness, respiratory failure, and dysautonomia. Clinical examination is essential for detecting a brainstem dysfunction that may be supported by neuroimaging, electrophysiological, autonomic, and respiratory assessments. Brainstem dysfunction mainly results from secondary insult and might contribute to critical illness-related mortality, organ dysfunction, immune dysregulation, delayed awakening, and delirium. The assessment of the brainstem should then be included in the routine neuromonitoring of critically ill patients.

Availability of data and materials

Not applicable

Abbreviations

ADEM:

Acute disseminated encephalomyelitis

ANS:

Autonomic nervous system

ARAS:

Ascending reticular activating system

BAEP:

Brainstem auditory evoked potentials

BP:

Blood pressure

BRASS:

Brainstem Reflexes Assessment Sedation Scale

CAM-ICU:

Confusion Assessment Method for the ICU

CRS-R:

Coma Recovery Scale-Revised

CSF:

Cerebrospinal fluid

ECG:

Electrocardiogram

EEG:

Electroencephalogram

EMG:

Electromyogram

FOUR:

Full Outline of UnResponsiveness

GABA:

Gamma-aminobutyric acid

GCS:

Glasgow Coma Scale

GRpF:

Parafacial respiratory group

HF:

High frequency

HR:

Heart rate

ICCT:

Intracranial conduction time

ICDSC:

Intensive care delirium screening checklist

ICU:

Intensive care unit

IPCT:

Intrapontine conduction time

IPL:

Inter-peak latencies

LC:

Locus coeruleus

LF:

Low frequency

MCS:

Minimally conscious state

MRI:

Magnetic resonance imaging

MS:

Multiple sclerosis

MSA:

Multiple systematrophy

NMDA:

N-methyl-d-aspartate

NMO:

Neuromyelitis optica

P0.1:

Occlusion pressure measurement

PCR:

Polymerase chain reaction

PreBotC:

Pre-Botzinger complex

PTSD:

Post-traumatic stress disorder

RASS:

Richmond Agitation Sedation Scale

RE:

Rhombencephalitis

RR:

Respiratory rate

SSEP:

Somatosensory evoked potentials

TDM:

Tomodensitometry

Ti:

Inspiration duration

Vt:

Tidal volume

References

  1. Hurley RA, Flashman LA, Chow TW, Taber KH. The brainstem: anatomy, assessment, and clinical syndromes. J Neuropsychiatry Clin Neurosci. 2010;22(1):iv 1-7.

    PubMed  PubMed Central  Google Scholar 

  2. Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael JC, et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med août. 1999;160(2):458–65.

    CAS  Google Scholar 

  3. Sharshar T, Porcher R, Siami S, Rohaut B, Bailly-Salin J, Hopkinson NS, et al. Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med août. 2011;39(8):1960–7.

    Google Scholar 

  4. Sharshar T, Gray F, Lorin de la Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet Lond Engl. 2003;362(9398):1799–805.

    CAS  Google Scholar 

  5. Mazeraud A, Pascal Q, Verdonk F, Heming N, Chrétien F, Sharshar T. Neuroanatomy and physiology of brain dysfunction in sepsis. Clin Chest Med. 2016;37(2):333–45.

    PubMed  Google Scholar 

  6. Quattrocchi CC, Errante Y, Rossi Espagnet MC, Galassi S, Della Sala SW, Bernardi B, et al. Magnetic resonance imaging differential diagnosis of brainstem lesions in children. World J Radiol. 2016;8(1):1–20.

    PubMed  PubMed Central  Google Scholar 

  7. Smith E, Delargy M. Locked-in syndrome. BMJ. 2005;330(7488):406–9.

    PubMed  PubMed Central  Google Scholar 

  8. Handley A, Medcalf P, Hellier K, Dutta D. Movement disorders after stroke. Age Ageing Mai. 2009;38(3):260–6.

    Google Scholar 

  9. Citerio G, Murphy PG. Brain death: the European perspective. Semin Neurol. 2015;35(2):139–44.

    PubMed  Google Scholar 

  10. Payen J-F, Isnardon S, Lavolaine J, Bouzat P, Vinclair M, Francony G. Pupillometry in anesthesia and critical care. Ann Fr Anesth Reanim. 2012;31(6):e155–9.

    PubMed  Google Scholar 

  11. André-Obadia N, Zyss J, Gavaret M, Lefaucheur J-P, Azabou E, Boulogne S, et al. Recommendations for the use of electroencephalography and evoked potentials in comatose patients. Neurophysiol Clin Clin Neurophysiol. 2018;48(3):143–169.

    PubMed  Google Scholar 

  12. Parvizi J, Damasio AR. Neuroanatomical correlates of brainstem coma. Brain J Neurol. 2003;126(Pt 7):1524–36.

    Google Scholar 

  13. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005;437(7063):1257–63.

    CAS  PubMed  Google Scholar 

  14. Plum F, Posner JB. The diagnosis of stupor and coma. Contemp Neurol Ser. 1972;10:1–286.

    CAS  PubMed  Google Scholar 

  15. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513–20.

    PubMed  PubMed Central  Google Scholar 

  16. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703–10.

    CAS  PubMed  Google Scholar 

  17. Laureys S, Celesia GG, Cohadon F, Lavrijsen J, León-Carrión J, Sannita WG, et al. Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome. BMC Med. 2010;8:68.

    PubMed  PubMed Central  Google Scholar 

  18. Naccache L. Reply: Response to « Minimally conscious state or cortically mediated state? ». Brain J Neurol. 2018;141(4):e27.

    Google Scholar 

  19. Giacino JT, Ashwal S, Childs N, Cranford R, Jennett B, Katz DI, et al. The minimally conscious state: definition and diagnostic criteria. Neurology. 2002;58(3):349–53.

    PubMed  Google Scholar 

  20. Giacino JT, Katz DI, Schiff ND, Whyte J, Ashman EJ, Ashwal S, et al. Practice guideline update recommendations summary: disorders of consciousness: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research. Arch Phys Med Rehabil. 2018;99(9):1699–709.

    PubMed  Google Scholar 

  21. Bourdillon P, Hermann B, Sitt JD, Naccache L. Electromagnetic brain stimulation in patients with disorders of consciousness. Front Neurosci. 2019;13:223.

    PubMed  Google Scholar 

  22. Corazzol M, Lio G, Lefevre A, Deiana G, Tell L, André-Obadia N, et al. Restoring consciousness with vagus nerve stimulation. Curr Biol CB. 2017;27(18):R994–6.

    CAS  PubMed  Google Scholar 

  23. Geddes MR, Tie Y, Gabrieli JDE, McGinnis SM, Golby AJ, Whitfield-Gabrieli S. Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder. Cortex J Devoted Study Nerv Syst Behav janv. 2016;74:96–106.

    Google Scholar 

  24. Fu X, Lu Z, Wang Y, Huang L, Wang X, Zhang H, et al. A clinical research study of cognitive dysfunction and affective impairment after isolated brainstem stroke. Front Aging Neurosci. 2017;9:400.

    PubMed  PubMed Central  Google Scholar 

  25. Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med. 2010;363(27):2638–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Wijdicks EFM, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: the FOUR score. Ann Neurol. 2005;58(4):585–93.

    PubMed  Google Scholar 

  27. Nolan JP, Soar J, Cariou A, Cronberg T, Moulaert VRM, Deakin CD, et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines for post-resuscitation care 2015: section 5 of the European Resuscitation Council guidelines for resuscitation 2015. Resuscitation. 2015;95:202–22.

    PubMed  Google Scholar 

  28. Ely EW, Truman B, Shintani A, Thomason JWW, Wheeler AP, Gordon S, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983–91.

    PubMed  Google Scholar 

  29. Rohaut B, Porcher R, Hissem T, Heming N, Chillet P, Djedaini K, et al. Brainstem response patterns in deeply-sedated critically-ill patients predict 28-day mortality. PLoS One. 2017;12(4):e0176012.

    PubMed  PubMed Central  Google Scholar 

  30. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001;27(5):859–64.

    CAS  PubMed  Google Scholar 

  31. Agarwal S, Morris N, Der-Nigoghossian C, May T, Brodie D. The influence of therapeutics on prognostication after cardiac arrest. Curr Treat Options Neurol. 2019;21(12):60.

    PubMed  Google Scholar 

  32. Amantini A, Grippo A, Fossi S, Cesaretti C, Piccioli A, Peris A, et al. Prediction of « awakening » and outcome in prolonged acute coma from severe traumatic brain injury: evidence for validity of short latency SEPs. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2005;116(1):229–35.

    Google Scholar 

  33. Haupt WF, Hojer C, Pawlik G. Prognostic value of evoked potentials and clinical grading in primary subarachnoid haemorrhage. Acta Neurochir. 1995;137(3–4):146–50 discussion 150.

    CAS  PubMed  Google Scholar 

  34. Azabou E, Rohaut B, Heming N, Magalhaes E, Morizot-Koutlidis R, Kandelman S, et al. Early impairment of intracranial conduction time predicts mortality in deeply sedated critically ill patients: a prospective observational pilot study. Ann Intensive Care. 2017;7(1):63.

    PubMed  PubMed Central  Google Scholar 

  35. De Santis P, Lamanna I, Mavroudakis N, Legros B, Vincent J-L, Creteur J, et al. The potential role of auditory evoked potentials to assess prognosis in comatose survivors from cardiac arrest. Resuscitation. 2017;120:119–24.

    PubMed  Google Scholar 

  36. García-Larrea L, Artru F, Bertrand O, Pernier J, Mauguière F. The combined monitoring of brain stem auditory evoked potentials and intracranial pressure in coma. A study of 57 patients. J Neurol Neurosurg Psychiatry. 1992;55(9):792–8.

    PubMed  PubMed Central  Google Scholar 

  37. Sohmer H, Freeman S, Gafni M, Goitein K. The depression of the auditory nerve-brain-stem evoked response in hypoxaemia--mechanism and site of effect. Electroencephalogr Clin Neurophysiol. 1986;64(4):334–8.

    CAS  PubMed  Google Scholar 

  38. Rossetti AO, Rabinstein AA, Oddo M. Neurological prognostication of outcome in patients in coma after cardiac arrest. Lancet Neurol. 2016;15(6):597–609.

    PubMed  Google Scholar 

  39. Benghanem S, Paul M, Charpentier J, Rouhani S, Ben Hadj Salem O, Guillemet L, et al. Value of EEG reactivity for prediction of neurologic outcome after cardiac arrest: Insights from the Parisian registry. Resuscitation. 2019;142:168–74.

    PubMed  Google Scholar 

  40. Kujala MV, Törnqvist H, Somppi S, Hänninen L, Krause CM, Vainio O, et al. Reactivity of dogs’ brain oscillations to visual stimuli measured with non-invasive electroencephalography. PLoS One. 2013;8(5):e61818.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Admiraal MM, Gilmore EJ, Van Putten MJAM, Zaveri HP, Hirsch LJ, Gaspard N. Disruption of brain-heart coupling in sepsis. J Clin Neurophysiol Off Publ Am Electroencephalogr Soc. 2017;34(5):413–20.

    Google Scholar 

  42. Azabou E, Magalhaes E, Braconnier A, Yahiaoui L, Moneger G, Heming N, et al. Early standard electroencephalogram abnormalities predict mortality in septic intensive care unit patients. PLoS One. 2015;10(10):e0139969.

    PubMed  PubMed Central  Google Scholar 

  43. Azabou E, Navarro V, Kubis N, Gavaret M, Heming N, Cariou A, et al. Value and mechanisms of EEG reactivity in the prognosis of patients with impaired consciousness: a systematic review. Crit Care Lond Engl. 2018;22(1):184.

    Google Scholar 

  44. Ongerboer de Visser BW, Kuypers HG. Late blink reflex changes in lateral medullary lesions. An electrophysiological and neuro-anatomical study of Wallenberg’s Syndrome. Brain J Neurol. 1978;101(2):285–94.

    CAS  Google Scholar 

  45. Buonaguidi R, Rossi B, Sartucci F, Ravelli V. Blink reflexes in severe traumatic coma. J Neurol Neurosurg Psychiatry. 1979;42(5):470–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Wehrwein EA, Orer HS, Barman SM. Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system. Compr Physiol. 2016;6(3):1239–78.

    PubMed  Google Scholar 

  47. Swenne CA. Baroreflex sensitivity: mechanisms and measurement. Neth Heart J févr. 2013;21(2):58–60.

    CAS  Google Scholar 

  48. Stober T, Sen S, Anstätt T, Bette L. Correlation of cardiac arrhythmias with brainstem compression in patients with intracerebral hemorrhage. Stroke. 1988;19(6):688–92.

    CAS  PubMed  Google Scholar 

  49. Smith M. Physiologic changes during brain stem death--lessons for management of the organ donor. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2004;23(9 Suppl):S217–22.

    Google Scholar 

  50. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985;248(1 Pt 2):H151–3.

    CAS  PubMed  Google Scholar 

  51. Bremner F, Smith S. Pupil findings in a consecutive series of 150 patients with generalised autonomic neuropathy. J Neurol Neurosurg Psychiatry. 2006;77(10):1163–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Smith JC, Ellenberger HH, Ballanyi K, Richter DW, Feldman JL. Pre-Bötzinger complex: a brainstem region that may generate respiratory rhythm in mammals. Science. 1991;254(5032):726–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Feldman JL, Del Negro CA. Looking for inspiration: new perspectives on respiratory rhythm. Nat Rev Neurosci. 2006;7(3):232–42.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Fiamma M-N, Straus C, Thibault S, Wysocki M, Baconnier P, Similowski T. Effects of hypercapnia and hypocapnia on ventilatory variability and the chaotic dynamics of ventilatory flow in humans. Am J Physiol Regul Integr Comp Physiol. 2007;292(5):R1985–93.

    CAS  PubMed  Google Scholar 

  55. Benarroch EE. Brainstem integration of arousal, sleep, cardiovascular, and respiratory control. Neurology. 2018;91(21):958–66.

    PubMed  Google Scholar 

  56. Sharman M, Gallea C, Lehongre K, Galanaud D, Nicolas N, Similowski T, et al. The cerebral cost of breathing: an fMRI case-study in congenital central hypoventilation syndrome. PLoS One. 2014; [cité 29 oct 2018];9(9). Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182437/.

  57. Muzumdar H, Arens R. Central alveolar hypoventilation syndromes. Sleep Med Clin. 2008;3(4):601–15.

    PubMed  PubMed Central  Google Scholar 

  58. Sampath V, Gowda MR, Vinay HR, Preethi S. Persistent hiccups (singultus) as the presenting symptom of lateral medullary syndrome. Indian J Psychol Med. 2014;36(3):341–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Mégarbane B, Hreiche R, Pirnay S, Marie N, Baud FJ. Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences. Toxicol Rev. 2006;25(2):79–85.

    PubMed  Google Scholar 

  60. Schmalgemeier H, Bitter T, Fischbach T, Horstkotte D, Oldenburg O. C-reactive protein is elevated in heart failure patients with central sleep apnea and Cheyne-Stokes respiration. Respir Int Rev Thorac Dis. 2014;87(2):113–20.

    CAS  Google Scholar 

  61. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med. 1999;341(13):949–54.

    CAS  PubMed  Google Scholar 

  62. Schmidt M, Kindler F, Gottfried SB, Raux M, Hug F, Similowski T, et al. Dyspnea and surface inspiratory electromyograms in mechanically ventilated patients. Intensive Care Med. 2013;39(8):1368–76.

    PubMed  Google Scholar 

  63. Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, et al. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med. 2019;380(26):2506–17.

    PubMed  Google Scholar 

  64. Keys TE. Historical vignettes: Dr. Arthur Ernest Guedel 1883-1956. Anesth Analg. 1975;54(4):442–3.

    CAS  PubMed  Google Scholar 

  65. Foo CC, Loan J, Brennan PM. The relationship of the FOUR score to patient outcome: a systematic review. J Neurotrauma. 2019;36(17):2469-2483.

    PubMed  Google Scholar 

  66. Wysocki M, Cracco C, Teixeira A, Mercat A, Diehl J-L, Lefort Y, et al. Reduced breathing variability as a predictor of unsuccessful patient separation from mechanical ventilation. Crit Care Med. 2006;34(8):2076–83.

    PubMed  Google Scholar 

  67. Zielske J, Bohne S, Brunkhorst FM, Axer H, Guntinas-Lichius O. Acute and long-term dysphagia in critically ill patients with severe sepsis: results of a prospective controlled observational study. Eur Arch Otorhinolaryngol. 2014;271(11):3085–93.

    PubMed  Google Scholar 

  68. Prescott HC, Langa KM, Iwashyna TJ. Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions. JAMA. 2015;313(10):1055–7.

    PubMed  PubMed Central  Google Scholar 

  69. Sharshar T, Gray F, Poron F, Raphael JC, Gajdos P, Annane D. Multifocal necrotizing leukoencephalopathy in septic shock. Crit Care Med. 2002;30(10):2371–5.

    CAS  PubMed  Google Scholar 

  70. Chuang Y-C, Tsai J-L, Chang AYW, Chan JYH, Liou C-W, Chan SHH. Dysfunction of the mitochondrial respiratory chain in the rostral ventrolateral medulla during experimental endotoxemia in the rat. J Biomed Sci. 2002;9(6 Pt 1):542–8.

    CAS  PubMed  Google Scholar 

  71. Blomqvist A, Engblom D. Neural mechanisms of inflammation-induced fever. Neuroscientist. 2018;24(4):381–99.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Roth J, Harré E-M, Rummel C, Gerstberger R, Hübschle T. Signaling the brain in systemic inflammation: role of sensory circumventricular organs. Front Biosci J Virtual Libr. 2004;9:290–300.

    CAS  Google Scholar 

  73. Mouri S, Tripon S, Rudler M, Mallet M, Mayaux J, Thabut D, et al. FOUR score, a reliable score for assessing overt hepatic encephalopathy in cirrhotic patients. Neurocrit Care. 2015;22(2):251–7.

    CAS  PubMed  Google Scholar 

  74. de Castilho FM, Ribeiro ALP, da Silva JLP, Nobre V, de Sousa MR. Heart rate variability as predictor of mortality in sepsis: a prospective cohort study. PLoS One. 2017;12(6):e0180060.

    PubMed  PubMed Central  Google Scholar 

  75. Swan JT, Fitousis K, Hall JB, Todd SR, Turner KL. Antipsychotic use and diagnosis of delirium in the intensive care unit. Crit Care Lond Engl. 2012;16(3):R84.

    Google Scholar 

  76. Reade MC. Dexmedetomidine: what next? Ann Transl Med. 2016;4(12) Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930513/. [cité 21 avr 2019].

    PubMed  PubMed Central  Google Scholar 

  77. Janz DR, Abel TW, Jackson JC, Gunther M, Heckers S, Ely EW. Brain autopsy findings in ICU patients previously suffering from delirium: a pilot study. J Crit Care. 2010;25(3):538.e7–12.

    Google Scholar 

  78. Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol. 2012;8(12):743–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Bonaz B, Bazin T, Pellissier S. The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci. 2018;12:49.

    PubMed  PubMed Central  Google Scholar 

  80. Scanzano A, Cosentino M. Adrenergic regulation of innate immunity: a review. Front Pharmacol. 2015;6 Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534859/. [cité 4 mai 2019].

  81. Kim T-H, Kim S-J, Lee S-M. Stimulation of the α7 nicotinic acetylcholine receptor protects against sepsis by inhibiting Toll-like receptor via phosphoinositide 3-kinase activation. J Infect Dis. 2014;209(10):1668–77.

    CAS  PubMed  Google Scholar 

  82. Zhang Q, Lu Y, Bian H, Guo L, Zhu H. Activation of the α7 nicotinic receptor promotes lipopolysaccharide-induced conversion of M1 microglia to M2. Am J Transl Res. 2017;9(3):971–85.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. Zeiler FA, Zeiler KJ, Teitelbaum J, Gillman LM, West M. VNS for refractory status epilepticus. Epilepsy Res. 2015;112:100–13.

    CAS  PubMed  Google Scholar 

  84. Feldman D, Elton TS, Menachemi DM, Wexler RK. Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine. Vasc Health Risk Manag. 2010;6:387–97.

    PubMed  PubMed Central  Google Scholar 

  85. Chacko CJ, Gopal S. Systematic review of use of β-blockers in sepsis. J Anaesthesiol Clin Pharmacol. 2015;31(4):460–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Steptoe A, Ronaldson A, Kostich K, Lazzarino AI, Urbanova L, Carvalho LA. The effect of beta-adrenergic blockade on inflammatory and cardiovascular responses to acute mental stress. Brain Behav Immun. 2018;70:369–75.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the reviewers for their comments and suggestions to improve our manuscript.

Funding

Jan Claassen is supported grant funding from the NIH R01 NS106014 and R03 NS112760, and the DANA Foundation.

Author information

Author notes

  1. Benjamin Rohaut and Tarek Sharshar contributed equally to this work.

Authors and Affiliations

  1. Department of Neurology, Neuro-ICU, Sorbonne University, APHP Pitié-Salpêtrière Hospital, Paris, France

    Sarah Benghanem & Benjamin Rohaut

  2. Medical ICU, Cochin Hospital, AP-HP, Paris, France

    Sarah Benghanem

  3. Department of Neuro-ICU, GHU-Paris, Paris-Descartes University, Paris, France

    Aurélien Mazeraud & Tarek Sharshar

  4. Laboratory of Experimental Neuropathology, Pastuer Institute, Paris, France

    Aurélien Mazeraud & Tarek Sharshar

  5. Department of Physiology, Clinical Neurophysiology Unit, APHP, Raymond Poincaré Hospital, University of Versailles Saint Quentin en Yvelines, Garches, France

    Eric Azabou

  6. Department of Intensive Care Medicine, Saint-Joseph Hospital, Paris, France

    Vibol Chhor

  7. Intensive Care Unit and Postgraduate Program, Instituto Nacional de Câncer, Rio de Janeiro, Brazil

    Cassia Righy Shinotsuka

  8. D’Or Institute for Research and Education, Rio de Janeiro, Rio de Janeiro, Brazil

    Cassia Righy Shinotsuka

  9. Department of Neurology, Neuro-ICU, Columbia University, New York, NY, USA

    Jan Claassen & Benjamin Rohaut

  10. Institut du Cerveau et de la Moelle épinière, ICM, INSERM UMRS 1127, CNRS UMR 7225, Pitié- Salpêtrière Hospital, Paris, F-75013, France

    Benjamin Rohaut

Authors
  1. Sarah Benghanem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aurélien Mazeraud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric Azabou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vibol Chhor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cassia Righy Shinotsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jan Claassen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Benjamin Rohaut
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tarek Sharshar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SB, AM, BR, and EA drafted the manuscript. JC, CRS, VB, and TS critically revised the manuscript for important intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Tarek Sharshar.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benghanem, S., Mazeraud, A., Azabou, E. et al. Brainstem dysfunction in critically ill patients. Crit Care 24, 5 (2020). https://doi.org/10.1186/s13054-019-2718-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13054-019-2718-9

Keywords

Critical Care

ISSN: 1364-8535